BPTHBIO-PATH HOLDINGS INC

Nasdaq biopathholdings.com


$ 2.65 $ 0.05 (1.81 %)    

Thursday, 09-May-2024 09:58:47 EDT
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 2.81
$ 2.65
$ 0.00 x 0
$ 0.00 x 0
$ 2.65 - $ 2.65
$ 2.35 - $ 44.80
45,945
na
1.34M
$ 0.93
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-07-2024 12-31-2023 10-K
2 08-14-2023 06-30-2023 10-Q
3 05-11-2023 03-31-2023 10-Q
4 03-30-2023 12-31-2022 10-K
5 11-14-2022 09-30-2022 10-Q
6 08-15-2022 06-30-2022 10-Q
7 05-16-2022 03-31-2022 10-Q
8 03-10-2022 12-31-2021 10-K
9 11-10-2021 09-30-2021 10-Q
10 08-12-2021 06-30-2021 10-Q
11 05-13-2021 03-31-2021 10-Q
12 03-09-2021 12-31-2020 10-K
13 11-12-2020 09-30-2020 10-Q
14 08-13-2020 06-30-2020 10-Q
15 05-14-2020 03-31-2020 10-Q
16 03-05-2020 12-31-2019 10-K
17 11-14-2019 09-30-2019 10-Q
18 08-14-2019 06-30-2019 10-Q
19 05-15-2019 03-31-2019 10-Q
20 03-19-2019 12-31-2018 10-K
21 11-14-2018 09-30-2018 10-Q
22 08-14-2018 06-30-2018 10-Q
23 05-15-2018 03-31-2018 10-Q
24 04-02-2018 12-31-2017 10-K
25 11-09-2017 09-30-2017 10-Q
26 08-09-2017 06-30-2017 10-Q
27 05-10-2017 03-31-2017 10-Q
28 03-15-2017 12-31-2016 10-K
29 11-09-2016 09-30-2016 10-Q
30 08-09-2016 06-30-2016 10-Q
31 05-10-2016 03-31-2016 10-Q
32 03-15-2016 12-31-2015 10-K
33 11-09-2015 09-30-2015 10-Q
34 08-10-2015 06-30-2015 10-Q
35 05-11-2015 03-31-2015 10-Q
36 03-16-2015 12-31-2014 10-K
37 11-14-2014 09-30-2014 10-Q
38 08-14-2014 06-30-2014 10-Q
39 05-15-2014 03-31-2014 10-Q
40 03-31-2014 12-31-2013 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 bio-path-holdings-has-been-granted-israeli-patent-number-269608-titled-compositions-comprising-p-ethoxy-nucleic-acids-for-stat3-inhibition-for-use-in-treating-cancer-or-autoimmune-disease

https://israelpatents.justice.gov.il/search/en/patent-extract/269608

 bio-path-holdings-announces-12m-registered-direct-offering-with-some-institutional-investors-for-sale-of-375000-shares-of-its-common-stock-at-price-of-3225share

Bio-Path Holdings, Inc., (NASDAQ:BPTH) (the "Company" or "Bio-Path"), a biotechnology company leveraging its pr...

 roth-mkm-reiterates-buy-on-bio-path-hldgs-maintains-40-price-target

Roth MKM analyst Philip Shen reiterates Bio-Path Hldgs (NASDAQ:BPTH) with a Buy and maintains $40 price target.

 why-bio-path-stock-is-soaring
Why Bio-Path Stock Is Soaring
04/18/2024 16:40:52

Bio-Path Holdings shares are trading higher Thursday after the company announced the completion of its second dose cohort in Ph...

 dow-surges-over-100-points-dr-horton-posts-upbeat-earnings

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Thursday. Following the market...

Core News & Articles
Market-Moving News for April 18th
04/18/2024 12:35:31

BPTH: 98% | Bio-Path Holdings shares are trading higher after the company announced the completion of its second dose cohort in...

 bio-path-holdings-reveals-receipt-of-newly-issued-patents-in-mexico-australia-and-japan

Bio-Path has expanded its intellectual property portfolio by filing patent applications that are applicable to its technology a...

 bio-path-holdings-said-may-offer-and-sell-up-to-2m-of-common-stock-from-time-to-time-through-hc-wainwright-entered-into-at-market-offering-agreement-relating-to-shares-of-common-stock-offered-by-prospectus-supplement

-8-K/424B5

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION